Athira Pharma
ATHA
ATHA
54 hedge funds and large institutions have $5M invested in Athira Pharma in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 20 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less capital invested
Capital invested by funds: $10.5M → $5M (-$5.51M)
65% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 20
Holders
54
Holding in Top 10
–
Calls
$4K
Puts
$1K
Top Buyers
| 1 | +$121K | |
| 2 | +$14.1K | |
| 3 | +$8.11K | |
| 4 |
IF
Integrity Financial
Cheyenne,
Wyoming
|
+$5.73K |
| 5 |
Renaissance Technologies
New York
|
+$3.33K |
Top Sellers
| 1 | -$59K | |
| 2 | -$47.7K | |
| 3 | -$36.7K | |
| 4 |
Two Sigma Advisers
New York
|
-$27.4K |
| 5 |
BA
Bristlecone Advisors
Bellevue,
Washington
|
-$24.3K |
